These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 1981344

  • 1. Differential modulation of mouse brain biogenic amines by haloperidol and pimozide: implications in Tourette's syndrome.
    Messiha FS.
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1990; 97(1):43-7. PubMed ID: 1981344
    [Abstract] [Full Text] [Related]

  • 2. Genetics, haloperidol and pimozide: a comparative study in two mouse strains.
    Messiha FS.
    Neurotoxicology; 1991; 12(1):47-54. PubMed ID: 2014068
    [Abstract] [Full Text] [Related]

  • 3. Tourette's medications: effect on minor oxidative and reductive pathways of biogenic amines.
    Messiha FS.
    Neurosci Biobehav Rev; 1988; 12(3-4):215-8. PubMed ID: 3226645
    [Abstract] [Full Text] [Related]

  • 4. Biochemical pharmacology of Gilles de la Tourette's syndrome.
    Messiha FS.
    Neurosci Biobehav Rev; 1988; 12(3-4):295-305. PubMed ID: 3067157
    [Abstract] [Full Text] [Related]

  • 5. ECG changes during haloperidol and pimozide treatment of Tourette's disorder.
    Fulop G, Phillips RA, Shapiro AK, Gomes JA, Shapiro E, Nordlie JW.
    Am J Psychiatry; 1987 May; 144(5):673-5. PubMed ID: 3555126
    [Abstract] [Full Text] [Related]

  • 6. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder.
    Sallee FR, Nesbitt L, Jackson C, Sine L, Sethuraman G.
    Am J Psychiatry; 1997 Aug; 154(8):1057-62. PubMed ID: 9247389
    [Abstract] [Full Text] [Related]

  • 7. Prolactin monitoring of haloperidol and pimozide treatment in children with Tourette's syndrome.
    Sallee FR, Dougherty D, Sethuraman G, Vrindavanam N.
    Biol Psychiatry; 1996 Nov 15; 40(10):1044-50. PubMed ID: 8915564
    [Abstract] [Full Text] [Related]

  • 8. Pimozide: use in Tourette's syndrome.
    Colvin CL, Tankanow RM.
    Drug Intell Clin Pharm; 1985 Jun 15; 19(6):421-4. PubMed ID: 3891283
    [Abstract] [Full Text] [Related]

  • 9. Different effects of chronic administration of haloperidol and pimozide on dopamine metabolism in the rat brain.
    Karolewicz B, Antkiewicz-Michaluk L, Michaluk J, Vetulani J.
    Eur J Pharmacol; 1996 Oct 17; 313(3):181-6. PubMed ID: 8911913
    [Abstract] [Full Text] [Related]

  • 10. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome.
    Ross MS, Moldofsky H.
    Am J Psychiatry; 1978 May 17; 135(5):585-7. PubMed ID: 347954
    [Abstract] [Full Text] [Related]

  • 11. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome.
    Shapiro E, Shapiro AK, Fulop G, Hubbard M, Mandeli J, Nordlie J, Phillips RA.
    Arch Gen Psychiatry; 1989 Aug 17; 46(8):722-30. PubMed ID: 2665687
    [Abstract] [Full Text] [Related]

  • 12. The effect of penfluridol and some psychotropic drugs on monoamine metabolism in central nervous system.
    Nose T, Takemoto H.
    Eur J Pharmacol; 1975 Apr 17; 31(2):351-9. PubMed ID: 238856
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of pimozide in adults and children with Tourette's syndrome.
    Sallee FR, Pollock BG, Stiller RL, Stull S, Everett G, Perel JM.
    J Clin Pharmacol; 1987 Oct 17; 27(10):776-81. PubMed ID: 3480904
    [Abstract] [Full Text] [Related]

  • 14. Mouse strain-dependent effect of amantadine on motility and brain biogenic amines.
    Messiha FS.
    Arch Int Pharmacodyn Ther; 1989 Oct 17; 302():74-85. PubMed ID: 2484011
    [Abstract] [Full Text] [Related]

  • 15. Comparative studies of sulpiride and classical neuroleptics on induction of catalepsy, locomotor activity, and brain dopamine metabolism in mice.
    Fujiwara H.
    Pharmacol Biochem Behav; 1992 Feb 17; 41(2):301-8. PubMed ID: 1349435
    [Abstract] [Full Text] [Related]

  • 16. Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study.
    Bruggeman R, van der Linden C, Buitelaar JK, Gericke GS, Hawkridge SM, Temlett JA.
    J Clin Psychiatry; 2001 Jan 17; 62(1):50-6. PubMed ID: 11235929
    [Abstract] [Full Text] [Related]

  • 17. Gilles de la Tourette's syndrome: biochemical approaches.
    Van Woert MH, Jutkowitz R, Rosenbaum D, Bowers MB.
    Res Publ Assoc Res Nerv Ment Dis; 1976 Jan 17; 55():459-65. PubMed ID: 1070064
    [Abstract] [Full Text] [Related]

  • 18. Tourette syndrome: a follow-up study.
    Sandor P, Musisi S, Moldofsky H, Lang A.
    J Clin Psychopharmacol; 1990 Jun 17; 10(3):197-9. PubMed ID: 2115892
    [Abstract] [Full Text] [Related]

  • 19. Eye-blink rate in Tourette's syndrome.
    Karson CN, Kaufmann CA, Shapiro AK, Shapiro E.
    J Nerv Ment Dis; 1985 Sep 17; 173(9):566-9. PubMed ID: 3860628
    [Abstract] [Full Text] [Related]

  • 20. Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome.
    Regeur L, Pakkenberg B, Fog R, Pakkenberg H.
    J Neurol Neurosurg Psychiatry; 1986 Jul 17; 49(7):791-5. PubMed ID: 3462344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.